SBC

SBC Medical Group Holdings Incorporated Common Stock (SBC)

Stock · NASDAQ · Health Care

$5.18as of 10/16/2026

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 26, 2026

SBC Medical to Attend Investor Conferences in Oct 2026. SBC Medical announced it will take part in several investor conferences in October 2026. These events give the company a platform to discuss its strategy, financial performance, and future plans with potential investors. The conferences could increase visibility for SBC and help the company attract interest from the investment community.

Active signals

Support level
$3.06
Industry
Medical/Nursing Services

What SBC's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.

SignalTimesMedian 20-session returnHigher after 20 sessions
Volume Spike25-2.9%36%
Bollinger Band Breakout20-6.7%35%
Bollinger Band Breakdown13-1.0%46%
200-Day Moving Average TouchActive now6-7.7%33%
Any 20-session window (baseline)+0.2%51%

Computed by MarketWall from daily closing prices since July 13, 2023. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.

About SBC

SBC Medical Group Holdings Incorporated, together with its subsidiaries, provides management services to cosmetic treatment centers in Japan, Vietnam, the United States, and Singapore. The company offers advertising and marketing services across social media networks; staff management services, such as recruitment and training; booking reservations for franchisee clinic customers; assistance with franchisee employee…

Sector
Health Care
Industry
Medical/Nursing Services
Employees
863

Fundamentals

1-day range
$5.2$5.35
Market cap
$305.46M
P/E (trailing)
11.12
P/E (forward)
9.76
EPS (trailing)
$0.48
Dividend yield
—
Beta
0.57
Avg. volume
173.3K
52-week range
$2.78$5.61
Next earnings: November 13, 2026 · EPS estimate $0.12confirmed

How SBC Medical Group Holdings Incorporated Common Stock Makes Money

Where the revenue actually goes — FY2025 annual results

market-wall.comTotalRevenue$173.61MNet Income$50.99M (29%)SG&A$59.80M (34%)Cost of Revenue$46.32M (27%)Tax$31.02M (18%)SBC

Source: 10-K filed Mar 27, 2026 · via SEC EDGAR / Finnhub

Gross Profit$127.28M(73%)
Operating Income$67.49M(39%)

Forecasts

4 analyst ratings

Buy 86%
Hold 14%
Sell 0%
1-year price forecast
High
$11
+112.6%
Median
$8.5
+64.3%
Low
$7
+35.3%

SBC Medical Group Holdings Incorporated Common Stock Competitors

Chosen by industry and closest market cap.

  • SBC
    SBC Medical Group Holdings Incorporated Common Stock
    $5.16
    ▼ 2.64%
    Market cap $305.46MP/E 11.12
    $2.78$5.61
  • AIRS
    AirSculpt Technologies Inc. Common Stock
    $1.27
    ▼ 9.89%
    Market cap $336.50MP/E —
    $1.41$12
  • AUNA
    Auna SA Class A Ordinary Shares
    $5.32
    ▲ 0.38%
    Market cap $384.87MP/E 83.35
    $4.09$6.71
  • LFMD
    LifeMD Inc. Common Stock
    $2.34
    ▼ 4.88%
    Market cap $164.43MP/E 589.89
    $2.36$6.53
  • SRTA
    Strata Critical Medical Inc. Class A Common Stock
    $4.54
    ▲ 4.61%
    Market cap $494.53MP/E 9.58
    $3.95$6.5
  • STLN
    Starling Oncology Inc. Common Stock
    $6.43
    ▼ 7.02%
    Market cap $498.91MP/E —
    $4.85$7.13
  • NAKA
    Nakamoto Inc. Common Stock
    $7.13
    ▼ 11.87%
    Market cap $86.14MP/E —
    $3.33$42

P/E shows — for peers not currently carrying a live signal of their own.

Insider Activity

Insider Actions →
Acquired
0
Disposed
3.56M

Institutional Ownership

March 31, 2026

Total shares held
1.31M
Total value held
$5.49M
Institutional holders
46
Top holders this quarter
  • Unknown419.6K
  • Unknown295.8K
  • Unknown136.2K
  • Unknown91.1K
  • Unknown81.3K
  • Unknown45.1K
  • Unknown30.8K
  • Unknown25.1K
  • Unknown24.0K
  • Unknown18.2K

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.